logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
S

Stefano Molica

University of Naples Federico II

39H指数
392论文数
5.5K被引数
收录论文 67
发表时间
logo
Cardiovascular Safety Across Leading BTK Inhibitors in Relapsed/Refractory CLL: Results of a Network Meta-Analysis在复发/难治性CLL中主要BTK抑制剂的心血管安全性：一项网络Meta分析的结果
errEUROPEAN JOURNAL OF HAEMATOLOGY
IF2.3
err2026-08-01
err1
PREAI
errMolica, Stefano; Giannarelli, Diana; Allsup, David
err分享
err收藏
Bridging Trials and Real Life in Fixed-Duration BTKi-Venetoclax for CLL: A Delphi-Enhanced Synthesis Incorporating Artificial Intelligence (AI) Benchmarks固定疗程BTKi-维奈克拉联合治疗CLL：连接临床试验与真实世界的德尔菲增强综合分析，并纳入人工智能（AI）基准
errEUROPEAN JOURNAL OF HAEMATOLOGY
IF2.3
err2026-08-01
err0
PREAI
errMolica, Stefano; Lucignano, Mariano; Villa, Maria Rosaria; Mettivier, Laura; Graziani, Francesco; Sammartano, Vincenzo; Fresa, Alberto; Sica, Antonello; Nunziata, Giuseppe Rodolfo; Farina, Giuliana
err分享
err收藏
Beyond mechanisms: toward patient-centered choices in BTKi-venetoclax fixed-duration therapy for CLL超越机制：迈向CLL中BTKi-venetoclax固定疗程治疗的患者为中心的选择
errLeukemia
IF13.4
err2026-03-24
err0
errOAAI
errFrancesca R. Mauro; David Allsup; Stefano Molica
err分享
err收藏
Optimizing Fixed-Duration Ven-I Regimen in CLL: Expert Insight and AI Comparison优化固定疗程的Ven-I方案在CLL中的应用：专家见解与AI比较
errHematological Oncology
IF3.9
err2026-02-24
err0
PREAI
errV. Innao; A. Figuera; E. Cotzia; L. Caruso; G. Mineo; V. Di Martina; G. Penna; L. Nocilli; M. Poidomani; G. Tona; M. Porrazzo; L. Crucitti; G. Amato; M. C. Ingemi; I. Abbene; A. Greco; S. Mancuso; G. Motta; D. Giannarelli; A. Chiarenza; S. Molica
err分享
err收藏
Fixed-duration BTKi-venetoclax combinations in CLL: optimizing patient-centered care
errEXPERT REVIEW OF ANTICANCER THERAPY
IF2.8
err2025-11-01
err0
PREAI
errMolica, Stefano; Allsup, David
err分享
err收藏
Pirtobrutinib in Chronic Lymphocytic Leukemia: Navigating Resistance and the Personalisation of BTK-Targeted TherapyPirtobrutinib在慢性淋巴细胞白血病中的应用：克服耐药性与BTK靶向疗法的个体化
errCancers 2025, Vol. 17, Page 2974
IF0
err2025-09-23
err0
errOAAI
errStefano Molica; David Allsup
err分享
err收藏
SOHO State of the Art Updates and Next Questions | The Evolving Landscape of Prognostic Models in Chronic Lymphocytic LeukemiaSOHO 技术现状更新与后续问题 | 慢性淋巴细胞白血病预后模型的发展态势
errClinical Lymphoma Myeloma and Leukemia
IF2.7
err2025-05-14
err0
PREAI
errStefano Molica; Ahmad Ibrahim; David Allsup
err分享
err收藏
AMPLIFY: A second-generation BTK inhibitor for fixed-duration therapy in chronic lymphocytic leukemiaAMPLIFY：一种用于慢性淋巴细胞白血病固定疗程治疗的第二代BTK抑制剂
errMED
IF11.8
err2025-04-01
err0
PREAI
errMolica, S
err分享
err收藏
Integrating pre- and post-treatment biomarkers into prognostic models for chronic lymphocytic leukemia to enhance predictive performance
errEXPERT REVIEW OF MOLECULAR DIAGNOSTICS
IF3.6
err2024-12-10
err0
errOAAI
errMolica, Stefano
err分享
err收藏
Prevalence of BTK and PLCG2 Mutations in CLL Patients With Disease Progression on BTK Inhibitor Therapy: A Meta-Analysis
errAMERICAN JOURNAL OF HEMATOLOGY
IF9.9
err2024-12-06
err0
errOAAI
errMolica, Stefano; Allsup, David; Giannarelli, Diana
err分享
err收藏
Network meta-analysis of upfront fixed-duration therapies in chronic lymphocytic leukemia
errAMERICAN JOURNAL OF HEMATOLOGY
IF9.9
err2024-07-23
err0
PREAI
errMolica, Stefano; Allsup, David; Giannarelli, Diana
err分享
err收藏
Epcoritamab in B-cell malignancies: current status and prospects
errEXPERT OPINION ON BIOLOGICAL THERAPY
IF4
err2024-02-11
err0
errOAAI
errMolica, Stefano; Rossi, Marco; Allsup, David
err分享
err收藏
Impact of targeted agents on survival of chronic lymphocytic leukemia patients age >65 relative to age- and sex-matched population
errAMERICAN JOURNAL OF HEMATOLOGY
IF9.9
err2023-12-15
err4
errOAAI
errMolica, Stefano; Shanafelt, Tait D.; Allsup, David; Giannarelli, Diana
err分享
err收藏
International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27
errBLOOD ADVANCES
IF7.1
err2023-11-20
err2
errOAAI
errOerlemans, Simone; Efficace, Fabio; Shamieh, Omar; Borges, Fabio Cardoso; de Jong, Corine; Dong, Dong; Lehmann, Jens; Malak, Sandra; Petranovic, Duska; Scholz, Christian W.; Caocci, Giovanni; Molica, Stefano; Griskevicius, Laimonas; Nagele, Eva; Bredart, Anne; Carvalho, Elisabete; Xochelli, Aliki; van Rentergem, Joost Agelink; Alrjoob, Waleed; Mueller, Anja; Freitas, Ana Carolina; Cocks, Kim; Creutzberg, Carien; Kyriakou, Charalampia; van de Poll-Franse, Lonneke
err分享
err收藏
Targeting TP53 disruption in chronic lymphocytic leukemia: Current strategies and future directions针对慢性淋巴细胞白血病的TP53破坏: 当前策略和未来方向
errHEMATOLOGICAL ONCOLOGY
IF3.9
err2023-11-08
err1
errOAAI
errMolica, Stefano; Tam, Constantine; Allsup, David; Polliack, Aaron
err分享
err收藏
Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study患者对慢性淋巴细胞白血病治疗的偏好: 选择研究
errHEMATOLOGICAL ONCOLOGY
IF3.9
err2023-09-29
err6
errOAAI
errSportoletti, Paolo; Laurenti, Luca; Chiarenza, Annalisa; Gaidano, Gianluca; Albi, Elisa; Mauro, Francesca Romana; Trentin, Livio; Vallisa, Daniele; Pane, Fabrizio; Cuneo, Antonio; Albano, Francesco; Zamprogna, Giulia; Coscia, Marta; Gozzetti, Alessandro; Reda, Gianluigi; Caira, Morena; Finsinger, Paola; Gualberti, Giuliana; Iannella, Emilia; Malgieri, Simona; Molica, Stefano
err分享
err收藏
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study
errAMERICAN JOURNAL OF HEMATOLOGY
IF9.9
err2023-06-29
err2
errOAAI
errVisentin, Andrea; Mauro, Francesca Romana; Scarfo, Lydia; Gentile, Massimo; Farina, Lucia; Reda, Gianluigi; Ferrarini, Isacco; Proietti, Giulia; Derenzini, Enrico; Cibien, Francesca; Vitale, Candida; Sanna, Alessandro; Pietrasanta, Daniela; Marchetti, Monia; Murru, Roberta; Rigolin, Gian Matteo; Sportoletti, Paolo; Trimarco, Valentina; Cavarretta, Chiara Adele; Angotzi, Francesco; Cellini, Alessandro; Ruocco, Valeria; Zatta, Ivan; Laurenti, Luca; Molica, Stefano; Coscia, Marta; Ghia, Paolo; Foa, Robin; Cuneo, Antonio; Trentin, Livio
err分享
err收藏
International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20)
errCANCER
IF5.1
err2023-05-19
err3
errOAAI
errOerlemans, Simone; Efficace, Fabio; Kyriakou, Charalampia; Freitas, Ana Carolina; Shamieh, Omar; Creutzberg, Carien L.; Lehmann, Jens; Petranovic, Duska; Nagele, Eva; Bredart, Anne; Dong, Dong; Scholz, Christian W.; Caocci, Giovanni; Molica, Stefano; Griskevicius, Laimonas; Xochelli, Aliki; Kieffer, Jacobien M.; Agelink van Rentergem, Joost A.; Alrjoub, Waleed; Mueller, Anja; Gomes Da Silva, Maria; Alves da Costa, Filipa; Malak, Sandra; Cocks, Kim; van de Poll-franse, Lonneke, V
err分享
err收藏
Real-world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience慢性淋巴细胞白血病中venetoclax的真实世界证据: 意大利的经验
errHEMATOLOGICAL ONCOLOGY
IF3.9
err2023-02-17
err4
errOAAI
errLaurenti, Luca; Scarfo, Lydia; Frustaci, Anna Maria; Sanna, Alessandro; Iannella, Emilia; Caira, Morena; Finsinger, Paola; Schifano, Silvia; Neri, Benedetta; Molica, Stefano; Mauro, Francesca Romana
err分享
err收藏
RETRACTION: Prognostic models for chronic lymphocytic leukemia (CLL): a systematic review and meta-analysis (Retraction of 10.1038/S41375-022-01771-, 2022)
errLEUKEMIA
IF13.4
err2022-11-30
err0
PREAI
errMolica, Stefano; Giannarelli, Diana
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
T
Tait D. Shanafelt
H 指数: 131 · 论文数: 1.0K
N
Neil K. Aaronson
H 指数: 125 · 论文数: 653
P
Pier Luigi Zinzani
H 指数: 117 · 论文数: 1.8K
P
Piotr Rutkowski
H 指数: 113 · 论文数: 1.8K
G
Gianluca Gaïdano
H 指数: 113 · 论文数: 1.5K
查看更多